The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress
Open accessAbstract
Significance: Mammalian target of rapamycin complex 1 (mTORC1) inhibitors are commonly used as immunosuppressants in solid-organ transplantation and as antiproliferative agents in various cancers. Despite indications of serious renal adverse events caused by mTORC1 inhibition, the role of mTORC1 for renal epithelial function and homeostasis has remained elusive. Unexpectedly, tubular mTORC1 controls energy-driven urine-concentrating mechanisms by maintaining mitochondrial biogenesis. Under pathophysiological conditions, mTORC1-dependent mitochondrial biogenesis is essential for energy supply and adaptation in response to ischemia. These findings identify mTORC1 as an important regulator of tubular energy metabolism, transcellular transport processes, and ischemic stress responses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“mTORC1 might be essential for maintaining kidney tubular homeostasis in response to ischaemic stress”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [80]
In the citing paper
“However, the side effects of long-term or complete mTORC1 inhibition in kidney cells have been well-recognized, such as the early onset of proteinuria caused by specific inhibition of mTORC1 activity in podocytes in mice and the disruption of kidney tubular homeostasis caused by specific inhibition of mTORC1 activity in kidney tubular cells in mice51,80.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [80]
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Self-citationTemsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Hudes, G., Carducci, M., Tomczak, P., Dutcher, J., Figlin, R., Kapoor, A., Staroslawska, E., Sosman, J., McDermott, D., Bodrogi, I., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066838 · Cited by 3,647
Kim, D.-H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 2,986
Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
Baselga, J., Campone, M., Piccart, M., Burris, H. A., Rugo, H. S., Sahmoud, T., Noguchi, S., Gnant, M., Pritchard, K. I., Lebrun, F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109653 · Cited by 2,863
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A., & Hall, M. N. (2004) · Nature Cell Biology · doi:10.1038/ncb1183 · Cited by 2,114
Self-citationTargets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,006
Self-citationRaptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action
Hara, K., Maruki, Y., Long, X., Yoshino, K.-I., Oshiro, N., Hidayat, S., Tokunaga, C., Avruch, J., & Yonezawa, K. (2002) · Cell · doi:10.1016/s0092-8674(02)00833-4 · Cited by 1,810
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data
Dai, M. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni179 · Cited by 1,797
VEGF Inhibition and Renal Thrombotic Microangiopathy
Eremina, V., Jefferson, J. A., Kowalewska, J., Hochster, H., Haas, M., Weisstuch, J., Richardson, C., Kopp, J. B., Kabir, M. G., Backx, P. H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707330 · Cited by 1,504
mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex
Cunningham, J. T., Rodgers, J. T., Arlow, D. H., Vazquez, F., Mootha, V. K., & Puigserver, P. (2007) · Nature · doi:10.1038/nature06322 · Cited by 1,488
Guertin, D. A., Stevens, D. M., Thoreen, C. C., Burds, A. A., Kalaany, N. Y., Moffat, J., Brown, M., Fitzgerald, K. J., & Sabatini, D. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.007 · Cited by 1,415
GAGE: generally applicable gene set enrichment for pathway analysis
Luo, W., Friedman, M. S., Shedden, K., Hankenson, K. D., & Woolf, P. J. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-161 · Cited by 1,333
mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
Peterson, T. R., Sengupta, S. S., Harris, T. E., Carmack, A. E., Kang, S. A., Balderas, E., Guertin, D. A., Madden, K. L., Carpenter, A. E., Finck, B. N., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.034 · Cited by 1,229
Bissler, J. J., Kingswood, J. C., Radzikowska, E., Zonnenberg, B. A., Frost, M., Belousova, E., Sauter, M., Nonomura, N., Brakemeier, S., de Vries, P. J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61767-x · Cited by 880
Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models
Brooks, C., Wei, Q., Cho, S.-G., & Dong, Z. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37829 · Cited by 735 · cited 1×
“The proximal tubule probably is the most energy-consuming nephron segment with the highest abundance of mitochondria; this segment is not targeted by the Ksp promoter (4, 5, 25, 34).”
BackgroundBentzinger, C. F., Romanino, K., Cloëtta, D., Lin, S., Mascarenhas, J. B., Oliveri, F., Xia, J., Casanova, E., Costa, C. F., Brink, M., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.10.002 · Cited by 640 · cited 1×
“Raptor fl/fl mice have been described previously (38) and were crossed to KspCre (25) or Pax8rtTA (35) and TetOCre (39) animals.”
BackgroundSelf-citationSchieke, S. M., Phillips, D., McCoy, J. P., Aponte, A. M., Shen, R.-F., Balaban, R. S., & Finkel, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603536200 · Cited by 623
Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
Gödel, M., Hartleben, B., Herbach, N., Liu, S., Zschiedrich, S., Lu, S., Debreczeni-Mór, A., Lindenmeyer, M. T., Rastaldi, M.-P., Hartleben, G., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44774 · Cited by 547 · cited 1×
“Furthermore, mTORC2 deficiency alone did not show any morphological or functional abnormalities under baseline conditions, suggesting that mTORC2 partially compensates for and reduces pathophysiological disturbances caused by RAPTOR/mTORC1 deficiency, potentially by increasing AKT prosurvival signaling (32, 33).”
BackgroundSelf-citationEpithelial-Specific Cre/lox Recombination in the Developing Kidney and Genitourinary Tract
Shao, X., Somlo, S., & Igarashi, P. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000016444.90348.50 · Cited by 330
Traykova-Brauch, M., Schönig, K., Greiner, O., Miloud, T., Jauch, A., Bode, M., Felsher, D. W., Glick, A. B., Kwiatkowski, D. J., Bujard, H., et al. (2008) · Nature Medicine · doi:10.1038/nm.1865 · Cited by 304
Uncompensated polyuria in a mouse model of Bartter's syndrome
Takahashi, N., Chernavvsky, D. R., Gomez, R. A., Igarashi, P., Gitelman, H. J., & Smithies, O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090091297 · Cited by 264
A single-sample microarray normalization method to facilitate personalized-medicine workflows
Piccolo, S. R., Sun, Y., Campbell, J. D., Lenburg, M. E., Bild, A. H., & Johnson, W. E. (2012) · Genomics · doi:10.1016/j.ygeno.2012.08.003 · Cited by 243
AKT2 is essential to maintain podocyte viability and function during chronic kidney disease
Canaud, G., Bienaimé, F., Viau, A., Treins, C., Baron, W., Nguyen, C., Burtin, M., Berissi, S., Giannakakis, K., Muda, A. O., et al. (2013) · Nature Medicine · doi:10.1038/nm.3313 · Cited by 222
Self-citationATP and the Regulation of Renal Cell Function
Soltoff, S. P. (1986) · Annual Review of Physiology · doi:10.1146/annurev.ph.48.030186.000301 · Cited by 202
Sirolimus Does Not Exhibit Nephrotoxicity Compared to Cyclosporine in Renal Transplant Recipients
Morales, J. M., Wramner, L., Kreis, H., Durand, D., Campistol, J. M., Andres, A., Arenas, J., Nègre, E., Burke, J. T., & Groth, C. G. (2002) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2002.20507.x · Cited by 188
Physiology of Renal Sodium Transport
Greger, R. (2000) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40679-2 · Cited by 158
Delayed Graft Function and Cast Nephropathy Associated with Tacrolimus Plus Rapamycin Use
Smith, K. D., Wrenshall, L. E., Nicosia, R. F., Pichler, R. H., Marsh, C. L., Alpers, C. E., Polissar, N. L., & Davis, C. L. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000057542.86377.5a · Cited by 149
The WNK Kinase Network Regulating Sodium, Potassium, and Blood Pressure
Hoorn, E. J., Nelson, J. H., McCormick, J. A., & Ellison, D. H. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080827 · Cited by 145
Stoichiometry and coupling of active transport to oxidative metabolism in epithelial tissues
Mandel, L. J., & Balaban, R. S. (1981) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1981.240.5.f357 · Cited by 134
Angioblast-mesenchyme induction of early kidney development is mediated by Wt1 and Vegfa
Gao, X., Chen, X., Taglienti, M. E., Rumballe, B. A., Little, M. H., & Kreidberg, J. A. (2005) · Development · doi:10.1242/dev.02095 · Cited by 116
Primary active sodium transport, oxygen consumption, and ATP: Coupling and regulation
Mandel, L. J. (1986) · Kidney International · doi:10.1038/ki.1986.2 · Cited by 108
Lieberthal, W., Fuhro, R. L., Andry, C., Patel, V. A., & Levine, J. S. (2006) · Transplantation · doi:10.1097/01.tp.0000225772.22757.5e · Cited by 60
Role of SPAK and OSR1 signalling in the regulation of NaCl cotransporters
Mercier‐Zuber, A., & O’Shaughnessy, K. M. (2011) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283484b06 · Cited by 53
Rapamycin-induced phosphaturia
Kempe, D. S., Dërmaku‐Sopjani, M., Fröhlich, H., Sopjani, M., Umbach, A., Puchchakayala, G. R., Capasso, A., Weiss, F., Stübs, M., Föller, M., et al. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq172 · Cited by 44
Golbækdal, K. I., Nielsen, C. B., Djurhuus, J. C., & Pedersen, E. B. (1994) · Transplantation · doi:10.1097/00007890-199412000-00002 · Cited by 37
Tubular function in patients with hypokalemia induced by sirolimus after renal transplantation
Morales, J. M., Andrés, A., Domínguez‐Gil, B., Sierra, M. P., Arenas, J., Delgado, M. G.-C., Casal, M. C., & Rodicio, L. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00224-0 · Cited by 34
Effects of Everolimus on Oxidative Stress in Kidney Model of Ischemia/Reperfusion Injury
Kezić, A., Thaiss, F., Becker, J. U., Tsui, T. Y., & Bajčetić, M. (2013) · American Journal of Nephrology · doi:10.1159/000348496 · Cited by 29
Haller, M., Amatschek, S., Wilflingseder, J., Kainz, A., Bielesz, B. O., Pavik, I., Serra, A. L., Mohebbi, N., Biber, J., Wagner, C. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039229 · Cited by 19
Artunç, F., Ebrahim, A. M., Siraskar, B. D., Nasir, O., Rexhepaj, R., Amann, K., Friedrich, B., Risler, T., & Lang, F. J. W. (2009) · Kidney & Blood Pressure Research · doi:10.1159/000214439 · Cited by 18
An Organ Culture Model for the Study of Metanephric Development
Avner, E. D., Villee, D. B., Schneeberger, E. E., & Grupe, W. E. (1983) · The Journal of Urology · doi:10.1016/s0022-5347(17)52273-9 · Cited by 15
Physiopathology and diagnosis of nephrogenic diabetes insipidus
Devuyst, O. (2012) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.03.032 · Cited by 11
Golbækdal, K. I., Nielsen, C. B., Djurhuus, J. C., et al. (1994) · Transplantation · doi:10.1097/00007890-199412270-00002 · Cited by 9
Cited by
Mitochondrial energetics in the kidney
Bhargava, P., & Schnellmann, R. G. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.107 · Cited by 1,334
CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
Anders, H.-J., Huber, T. B., Isermann, B., & Schiffer, M. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0001-y · Cited by 796
Self-citationAutophagy in kidney homeostasis and disease
Tang, C., Livingston, M. J., Liu, Z., & Dong, Z. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0309-2 · Cited by 496
Cellular and molecular mechanisms of kidney fibrosis
Djudjaj, S., & Boor, P. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.06.002 · Cited by 475
Autophagy in acute kidney injury
Kaushal, G. P., & Shah, S. V. (2016) · Kidney International · doi:10.1016/j.kint.2015.11.021 · Cited by 389
Metadata
- Authors
- Grahammer, F., Haenisch, N., Steinhardt, F., Sandner, L., Roerden, M., Arnold, F., Cordts, T., Wanner, N., Reichardt, W., Kerjaschki, D., Ruegg, M. A., Hall, M. N., Moulin, P., Busch, H., Boerries, M., Walz, G., Artunc, F., & Huber, T. B.
- Affiliations
- University Medical Center Freiburg (DE)
- Universitätsklinikum Tübingen (DE)
- University of Freiburg (DE)
- University of Vienna (AT)
- Biozentrum Basel, University of Basel, 4056 Basel, Switzerland;
- University of Basel (CH)
- Novartis (Switzerland) (CH)
- German Cancer Research Center (DE)
- Renal Division, University Hospital Tübingen, 72076 Tübingen, Germany;
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2014-06-23
- Volume
- 111
- Issue
- 27
- Pages
- E2817-26
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4103333
- OpenAlex
- W2129481102
- Cited by
- 109
- References
- 43
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 10 · 2023: 9 · 2022: 10 · 2021: 13 · 2020: 9 · 2019: 5 · 2018: 7 · 2017: 7 · 2016: 13 · 2015: 7 · 2014: 4
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Update notices
- correction (2015-11-30)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- edoc (University of Basel) (acceptedVersion)
- edoc (University of Basel)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- mTORC1, raptors, renal ischemia-reperfusion injury, renal fibrosis, urinary concentrating defect, mitochondrial metabolism, mitochondrial biogenesis, countercurrent multiplication, transcellular transport, mTORC2, tubular apoptosis, tubular cell proliferation
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Animals, Homeostasis, Ischemia, Kidney Tubules, Magnetic Resonance Imaging, Polyuria, Transcription, Genetic, Blotting, Western, Multiprotein Complexes, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.